Drug Shortage Report for BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
Report ID | 154812 |
Drug Identification Number | 00037818 |
Brand name | BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP |
Common or Proper name | BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 9MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 25 x 10mL vial |
ATC code | B05CB |
ATC description | IRRIGATING SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-02-11 |
Estimated end date | 2022-08-31 |
Actual end date | 2022-08-01 |
Shortage status | Resolved |
Updated date | 2022-08-02 |
Company comments | Inventory is on preventative allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-08-02 | French | Compare |
v8 | 2022-08-02 | English | Compare |
v7 | 2022-06-22 | French | Compare |
v6 | 2022-06-22 | English | Compare |
v5 | 2022-02-12 | English | Compare |
v4 | 2022-02-11 | French | Compare |
v3 | 2022-02-11 | English | Compare |
v2 | 2022-02-11 | French | Compare |
v1 | 2022-02-11 | English | Compare |
Showing 1 to 9 of 9